Login / Signup

Safety and efficacy of pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID study): A prospective, randomised, single-blind, controlled trial.

Mohammad JavaherianAzadeh ShadmehrAbbasali KeshtkarMohammad Taghi BeigmohammadiNarges DabbaghipourAabis SyedBehrouz Attarbashi Moghadam
Published in: PloS one (2023)
Early PPT can be considered a safe and relatively effective therapeutic choice for patients with severe COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • open label
  • clinical trial
  • double blind
  • early onset
  • study protocol
  • pulmonary hypertension
  • randomized controlled trial
  • drug induced
  • intensive care unit